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Objective: To evaluate the response of rat subcutaneous tissue in implanted polyethylene tubes that were filled with GMTA Angelus and Portland cements containing different 
arsenic concentrations. Material and Methods: Atomic absorption spectrophotometry was 
utilized to obtain the values of the arsenic concentration in the materials. Thirty-six rats 
were divided into 3 groups of 12 animals for each experimental period. Each animal received 
two implants of polyethylene tubes filled with different test cements and the lateral of the 
tubes was used as a control group. After 15, 30 and 60 days of implantation, the animals 
were killed and the specimens were prepared for descriptive and morphometric analysis 
considering: inflammatory cells, collagen fibers, fibroblasts, blood vessels and other 
components. The results were analyzed utilizing the Kuskal-Wallis test and the Dunn´s 
Multiple test for comparison (p<0.05). Results: The materials showed, according to atomic 
absorption spectrophotometry, the following doses of arsenic: GMTA Angelus: 5.01 mg/kg, 
WPC Irajazinho: 0.69 mg/kg, GPC Minetti: 18.46 mg/kg and GPC Votoran: 10.76 mg/kg. 
In a 60-day periods, all specimens displayed a neoformation of connective tissue with a 
structure of fibrocellular aspect (capsule). Control groups and MTA Angelus produced the 
lower amount of inflammatory reaction and GPC Minetti, the highest reaction. Conclusions: 
There was no direct relationship between the concentration of arsenic present in the 
composition of the materials and the intensity of the inflammatory reactions. Higher values, 
as 18.46 mg/kg of arsenic in the cement, produce characteristics of severe inflammation 
reaction at the 60-day period. The best results were found in MTA angelus.
Keywords: Arsenic. Endodontics. Dental materials. Subcutaneous tissue reaction. Portland 
cement.
INTRODUCTION
MTA is a mixture of hydrophilic powder consisting 
of tricalcium silicate, tricalcium oxide, silicate oxide 
and tricalcium aluminate2,21. Several in vivo and in 
vitro studies demonstrated the beneficial properties 
of MTA, such as biocompatibility20, promoting 
dental pulp and periradicular tissue regeneration1, 
excellent sealing ability23,24 and antimicrobial 
effects8,22. Due to these properties, MTA has been 
recommended for several clinical applications. 
Portland cement (PC) is the main component 
of MTA25 and has been studied since 1999. Studies 
revealed similar chemical composition8,12,14, action 
mechanism10,11 and cytotoxicity17,19 for both 
materials. The only difference between them 
is the absence of bismuth oxide in PC, used as 
radiopacifier in MTA. It has been reported that 
Portland cement may contain some heavy metals 
in its composition, such as arsenic (As)3,4,7,15,18. The 
concentration of this metal varies according to the 
origin of the raw material used for the production 
of the Portland cement4.
As is a metalloid found in water, air and soil, 
in organic and inorganic forms and in different 
stages of oxidation. The trivalent and pentavalent 
stages are the most toxic11. The soluble As salts 
are easily absorbed orally and by inhalation, and 
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the extent of absorption depends on the solubility 
of the compound. From the bloodstream, it is 
deposited into tissues, liver, kidneys and lungs11. 
The chronic exposure to inorganic As is associated 
to the deleterious effects to human health, such as 
hyperkeratosis, hyperpigmentation, cardiovascular 
diseases, central nervous system and peripheral 
vascular disorders, skin cancer and gangrene in 
the limbs16.
Due to its high toxicity, As may cause generalized 
tissue necrosis in the oral cavity when used for 
endodontic purposes9,26. A study by Duarte, et al.7 
(2005) evaluated the release of As in two gray 
PCs, one white PC, MTA Angelus and MTA ProRoot 
and found similar As levels between the materials, 
much below the limit established by the ISO 9917-
1 specifications13, which state that a material may 
only be used in dental procedures when it does not 
contain more than 2 mg of As per kg of material.
Regarding the concerns of the arsenic content 
in PC and MTA, a previous study3 observed the 
presence of As in several materials, including white 
and gray MTA Angelus, white and gray PC, MTA 
ProRoot, PCM, MTA-Obtura and an experimental 
MTA. Only MTA-Obtura, white MTA Angelus and 
white PC (Irajazinho, Cimento Rio Branco, Rio de 
Janeiro, RJ, Brazil) presented levels below the limits 
recommended by ISO3.
Despite the variable presence of arsenic in 
these materials, no studies in the literature have 
compared the biocompatibility of Portland cement 
and MTA according to the arsenic concentrations. 
The aim of this study was to microscopically 
evaluate the tissue response in the subcutaneous 
tissue of rats to the implantation of polyethylene 
tubes containing MTA and Portland cements with 
different arsenic concentrations.
MATERIAL AND METHODS
Animals and sample grouping
The present study was approved and performed 
according to the guidelines of the Research and 
Ethics Committee of the Bauru School of Dentistry, 
University of São Paulo, Bauru, SP, Brazil (Process 
no. 024/2009). A total of 36 male animals (Rattus 
norvegicus albinus Wistar), approximately 2 to 3 
months old and weighing around 200±50 grams, 
were used for this experiment. The animals received 
appropriate granular food and water ad libitum.
The thirty-six rats were divided into 3 groups of 
12 animals per experimental period of 15, 30 and 
60 days and each animal received two-polyethylene 
tubes containing different cements. The following 
materials were investigated: group 1: Gray 
MTA Angelus (MTA - Angelus, Angelus Indústria 
de Produtos Odontológicos S/A, Londrina, PR, 
Brazil); group 2: White Portland cement Irajazinho 
(Irajazinho, Cimento Rio Branco, Rio de Janeiro, 
RJ, Brazil); group 3: Gray Portland cement Minetti 
(Minetti, Juan Minetti S/A, Cordoba, Cordoba, 
Argentine) and group 4: Gray Portland cement 
Votoran (Votoran, Votorantim Cimentos, Cubatão, 
SP, Brazil).
The cements were analyzed by the Hidrocepe 
- Quality Services Ltda. (Belo Horizonte-MG) 
laboratory, which quantified the levels of arsenic 
according to a previous related methodology3.
Sample preparation
The test materials were placed in sterile 
polyethylene tubes with 1.5 mm inner diameter 
and 10 mm length. GMTA Angelus (MTA - Angelus, 
Angelus Indústria de Produtos Odontológicos S/A, 
Londrina, PR, Brazil) was mixed according to the 
manufacturer’s instructions. The powder/liquid 
ratio used for the Portland cements was 1 g/0.35 
mL distilled water. The sterilized tubes were filled 
with the test materials with the aid of endodontic 
condensers.
Surgical procedures
The animals were anesthetized with 0.008 
mL/100 g of ketamine (Dopalen® - Vetbrands, 
CEVA, Paulínia, SP, Brazil) and 0.004 mL/100 g of 
xylazine hydrochloride 2% (Calmium® - Agener 
União, União Química, Embu-Guaçu, SP, Brazil). 
A dorsal shaving was performed, and the area 
was disinfected with an iodine solution (Riodene, 
Rioquímica Indústria Farmacêutica, São José do 
Rio Preto, SP, Brazil). The backs of the animals 
were incised over a length of 2 cm, using a no. 15 
blade (Embramac, Embramac - Empresa Brasileira 
de Materiais Cirúrgicos, Campinas, SP, Brazil) 
in a head-to-tail alignment orientation. A blunt 
dissecting instrument was used to create a 18 mm 
deep pocket in the subcutaneous tissue to receive 
the implants. Polyethylene tubes filled with the 
materials were then introduced into spaces created 
by a blunt dissection; one in each side, parallel to 
the incisions, and the skin was closed with 4.0 silk 
suture. The distance between the tubes was 16 
mm to avoid interaction between the materials. 
Each animal received 2 implants of the different 
materials. Immediately after implantation, the 
animals were observed until they recovered their 
physical activities with no feeding restrictions. The 
animals were seen every day for a maximum period 
of 60 days.
Histological procedures
At the end of each experimental period, 
the animals were anesthetized and killed by 
administrating high doses of anesthetics. Shaving 
and incision were performed and the tubes and 
surrounding tissues were removed with a safety 
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15 Days 30 Days 60 Days
MTA 2.0b(0-15)A 2.0a (0-10)B 1.0a(0-6)C
WPC 2.0b(0-16)A 1.0b (0-7)B 2.0b(0-10)A
GPC MINETTI 4.0d(0-21)A 2.0d(0-15)B 4.0d(0-18)A
GPC VOTORAN 6.0c(0-28)A 5.0c(0-20)A 3.0c(0-10)B
CONTROL 0a(0-4.39)A 0e(0-1)A 0e(0-0)B
Table 1- Numerical density of inflammatory cells in the capsule adjacent to the empty tubes (control group) and to the tubes 
filled with cements
Same letters represent absence of statistical significance. Uppercase letters represent period. Lowercase letters represent 
material
margin of 1 cm. The specimens were kept in 10% 
formaldehyde solution (Merck & Co, Darmstadt, 
Germany) for 2 weeks, until they were histologically 
processed.
The polyethylene tubes were removed from the 
specimens, which were then set in prepared paraffin 
blocks. Sections 5 µm thick were cut by a microtome 
and stained with hematoxylin and eosin and three 
sections from each specimen were selected.
Morphometric analysis
For histological analysis, 6 histological sections 
per animal of each cement were included. Each 
section was analyzed in ten microscopic fields from 
the region of interest. In total, 60 microscopic fields 
were evaluated per animal.
The volume density (Vvi) or the fraction of fibrous 
capsule volume occupied by the fibroblasts, collagen 
fibers, blood vessels, inflammatory infiltrate 
(including acute and chronic inflammatory cells) 
and other structures (spaces occupied by interstitial 
liquid) was determined by the point volumetric 
method, using an optical microscope (Aristoplan, 
Leitz Wetzlar, Germany) with a 100× objective 
and 8× Zeiss Kpl eyepiece containing a Zeiss II 
integration grid with 100 points symmetrically 
distributed over a quadrangular area. For this 
purpose, the number of points coinciding with 
each structure (Pi) and the total points analyzed 
(P) were determined to calculate the percentage 
of the studied structures and cells.
Statistical analysis
The data were analyzed using the Kruskal-Wallis 
test and when statistically significant differences 
were present among the groups, the Dunn’s Multiple 
Comparison test was utilized. A p value of less 
than 0.05 was considered statistically significant. 
Statistical analyses were performed utilizing the 
SigmaPlot 12 analysis.
RESULTS
The amount of arsenic (mg/kg) obtained from 
each material was: GPC Minetti: 18.46 mg/kg; GPC 
Votoran: 10.73 mg/kg; GMTA Angelus: 5.91 mg/
kg and WPC Irajazinho: 0.69 mg/kg.
Microscopic analysis
The analysis of each material includes 360 
microscopic areas (60 microscopic fields in 6 
animals). At the 15-, 30- and 60-day periods, all 
specimens displayed a neoformation of connective 
tissue with a structure of fibrocellular aspect 
(capsule). Summarized morphometric data of the 
volume density of collagen fibers, fibroblasts, blood 
vessels and inflammatory cells are presented in 
Table 1 and Table 2.
Overall, the lower amount of inflammatory 
cells was found at the 60-day period, significant 
differences were found among the materials 
(p>0.05). The control group showed the lower 
values of inflammatory cells, followed by MTA 
Angelus, WPC Irajazinho, Votoran cement and 
Minetti cement, which showed the higher values of 
inflammatory cells. Other statistical significances 
can be found in Table 1.
At 60 days, the experimental groups MTA 
Angelus, WPC Irajazinho and GPC Votoran 
showed similar vascular neoformation (Table 2) 
with exception of GPC Minetti and control group. 
Regarding the presence of collagen fibers there was 
an increment of this parameter at the 60-day period 
in the control group. The number of fibroblasts 
was constant. The GPC Minetti showed the lower 
values of collagen fibers in comparison to the other 
groups. MTA Angelus cement, WPC Irajazinho and 
GPC Votoran showed similar result. In addition, GPC 
Minetti showed the higher values of fibroblasts at 
the initial periods.
Morphologic analysis
MTA Angelus
At 15 days, a thick capsule was juxtaposed to 
the tubes filled with MTA implanted subcutaneously. 
2015;23(1):42-8
J Appl Oral Sci. 45
Rat subcutaneous tissue response to MTA Angelus and Portland cements containing different arsenic concentrations
Several inflammatory cells were seen mainly in 
the inner portion of the capsule. After 15 days, 
multinucleated giant cells were found adjacent 
to MTA (Figure 1). At 30 days, more organized 
capsules were found with collagen fibers containing 
several fibroblasts. Collagen fibers were thicker 
and blood vessels less numerous and there was 
fewer empty spaces. A significant reduction of the 
inflammatory process was verified after 30 and 
60 days in comparison to 15 days (Table 1). The 
inflammatory process contained mainly plasma 
cells and macrophages, which were mainly situated 
around the blood vessels. Usually, a connective 
tissue exhibiting well-defined bundles of collagen 
fibers was present at 60 days. Few interstitial 
spaces and several elongated fibroblasts were also 
found at this period (Figure 2).
WPC Irajazinho
At 15 days, a thick fibrous capsule was observed 
around the implanted material, besides disorganized 
collagen fiber network with several formed vessels 
and fibroblasts (Figure 1 and Table 2). After 15 
days of implantation, several inflammatory cells 
were present in the capsule and macrophages were 
often observed in close juxtaposition to the material 
(Figure 1). At 30 days, lymphocytes, macrophages 
and multinucleated giant cells were present 
throughout the capsule. At 60 days, the thickness 
of the fibrous capsule decreased and presented 
few inflammatory cells (Figure 2 and Table 1). 
Organized collagen fibers and several elongated 
fibroblasts with an arrangement rather parallel to 
cement surface constituted the capsule. At 30 days, 
a reduction in the number of inflammatory cells was 
verified when compared to 15 days; however, an 
increase in the amount of inflammatory cells was 
found at 60 days (Table 1).
GPC groups (Minetti and Votoran)
At 15 days, the capsule was thick with collagen 
fibers arranged around the cement. A disorganized 
collagen fiber network with several newly formed 
vessels and a large number of fibroblasts (Table 2) 
was present, showing high synthetic activity. A high 
numerical density of inflammatory cells was verified 
in the capsule surrounding the implants containing 
GPC (Table 1). Several mononuclear macrophages 
Histological events Experimental periods
15 days 30 days 60 days
       MTA Angelus®
Fibroblasts 7.00c(1-32)A 5.0a(1-17)B 7.0c(1-32)C
Collagen fibers 46.0c(0-87)A 42.0b(15-81)A 35.0a(16-75)B
Blood vessels 0e(0-16)A 1.0d(0-5)B 0a(0-16)A
WPC Irajazinho
Fibroblasts 5.0b(0-19)A 6.0b(0-27)B 4.0a,b(0-14)A
Collagen fibers 46.0c(13-86)A 50.5a(3-79)A 49.0b(13-86)A
Blood vessels 0.0d,e(0-9)A 0b(0-5)A 1.0b(0-6)A
GPC Minetti
Fibroblasts 13.5d(0-88)A 4.0a(1-17)B 4.00a(0-18)A
Collagen fibers 13.0a(0-86)A 48.0b(19-68)B 1.0d(0-5)C
Blood vessels 0.0b,e(0-9)A 1.0c,d(0-11)B 0d,e(0-5)C
GPC Votoran
Fibroblasts 5.0a,b(0-12)A 5.0a(0-39)A 3.0b(0-12)B
Collagen fibers 44.0c(20-75)A 40.5a(18-83)B 40a,c(20-75)C
Blood vessels 1.0c(0-19)A 1.0b,c(0-15)B 1c(0-6)A
Control (empty tube)
Fibroblasts 4.0a(0-8)A 4.5a(2-11)A 4.0a,b(0-7)B
Collagen fibers 27.0b(3-38)A 58.0c(11-76)B 88.0e(60-97)C
Blood vessels 0a(0-0)A 0a(0-1)A 0e(0-5)B
Table 2- Mean of density volume (%) and standard deviation of histological events shown in connective tissue (capsule) 
adjacent to the implanted materials and empty tube (control group)
Same letters represent absence of statistical significance. Uppercase letters represent period. Lowercase letters represent 
material
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Figure 1- Histological images of inflammatory cells infiltration at the end of implanted tubes at the end of the 15-day period. 
(A) GMTA. (B) WPC. (C) GPC Minetti. (D) GPC Votoran. (E) Control group. Presence of collagen fibers arranged to the 
cement (asterisks), fibroblasts (black arrows), blood vessels (blue arrows) and macrophages/multinucleated giant cells 
(yellow arrows). Hematoxylin and eosin staining, bars represent 50 µm
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and multinucleated giant cells in close juxtaposition 
to the implanted cement surface were seen in the 
capsule (Figure 1). Moreover, the inflammatory 
process contained mainly lymphocytes. At 60 days, 
the number of inflammatory cells was significantly 
lower in comparison to 15 days in the Votoran 
cement (Table 1). The Minetti cement showed an 
improvement of the inflammatory reaction at the 
30 days period but an increase in the inflammatory 
reaction was observed at the 60 days period 
(p>0.05). Besides the reduction in the inflammatory 
reaction in the Votoran cement, several fibroblasts 
and collagen fibers were present in the capsule. 
At 60 days, the capsule was formed by a dense 
connective tissue containing evident bundles of 
collagen fibers (Figure 2).
Control group (empty tube)
At 15 days, the capsule adjacent to the empty 
tubes implanted in the subcutaneous tissue exhibited 
a mild inflammatory process; evident fibroblasts and 
blood vessels were present (Table 2). The adjacent 
area of tube surface presented some macrophages 
and no other type of inflammatory cells (Table 1) 
was observed (Figure 1). At 30 days the capsule 
was formed by a typical dense connective tissue, in 
addition to a significant reduction in the number of 
inflammatory cells (Table 1). At 60 days, the fibrous 
capsule was well organized with denser collagen 
fibers, few interstitial spaces, several elongated 
fibroblasts and absence of inflammatory process 
(Table 1 and Figure 2).
DISCUSSION
Endodontic materials are frequently placed in 
close contact with the periodontium, such as pulp 
capping, apical barrier, perforation repair, root-end 
filling material, and orthograde filling material. Thus 
the materials require the necessary preliminary 
test, because the toxic components present in 
these materials could produce irritation or even 
degeneration of the surrounding tissues.
Implantation of endodontic materials into 
the subcutaneous connective tissue in rats is 
considered a valid secondary screening test for 
biocompatibility27. The implantation of materials in 
polyethylene tubes has been widely accepted. The 
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Figure 2- Histological images of inflammatory cells infiltration at the end of implanted tubes at the end of the 60-day period. 
(A) GMTA. (B) WPC. (C) GPC Minetti. (D) GPC Votoran. (E) Control group. Presence of collagen fibers arranged to the 
cement (asterisks), fibroblasts (black arrows), blood vessels (blue arrows) and macrophages/multinucleated giant cells 
(yellow arrows). Hematoxylin and eosin staining, bars represent 50 µm
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tubes help fix the material at the site to maintain 
proper contact between the material and tissues. In 
this study, the lateral walls of the polyethylene tubes 
were used as the control group because the material 
by itself has been proven to be biocompatible27, a 
finding that was confirmed in the current study.
The presence of arsenic in the Portland cement 
and the MTA is a problem with regards to 
biocompatibility14. Although a significant amount 
of arsenic is present in the different types of these 
materials3,4, its release is usually small6,7,15. The 
ISO 9917-1 standard13 specifies the limit of 2 mg/
kg for the total arsenic content in the materials 
and not for the release. Studies have shown that 
the levels of arsenic released by MTA Angelus and 
Portland cement are below what is considered toxic 
to human health7.
The materials analyzed in this study showed, 
according to atomic absorption spectrophotometry, 
the following doses of arsenic: GPC Minetti 18.46 
mg/kg, GPC Votoran 10.76 mg/kg, GMTA Angelus 
5.01 mg/kg and WPC Irajazinho 0.69 mg/kg. Overall, 
all materials in the three experimental periods 
showed a greater inflammatory response than the 
control group. The gray Portland cements Minetti 
and Votoran showed the highest concentration of 
arsenic in the atomic absorption spectrophotometry 
(18.46 mg/kg and 10.73 mg/kg, respectively) and 
were the materials that showed a more pronounced 
inflammatory response, specially GPC Minetti. 
However, the little amount of arsenic present in 
WPC Irajazinho did not necessarily represent a 
lower inflammatory reaction.
An interesting finding was observed in the GMTA 
Angelus group: even with a higher concentration 
of arsenic (5.91 mg/kg) according to the ISO 
standard, it showed statistically lower values of 
inflammatory response in comparison to WPC 
Irajazinho (0.69 mg/kg) in the initial and final 
periods. The lower inflammatory reaction in GMTA 
Angelus, compared to the other Portland cements 
may be related to the presence of some impurities 
and other heavy metals within these non-dental 
cements4,6,15,18 . This depends on where the mineral 
was extracted4, which may affect the proportion of 
heavy metals in the composition of the cement. 
Heavy metals are incorporated from the substitution 
of primary fuels to reduce costs with alternate 
fuels, which are usually wastes, and also by the 
utilization of wastes, an alternative inorganic 
raw material along with limestone and shale19. In 
addition to the arsenic content, Portland cement 
has been reported to contain more heavy metals, 
such as manganese and strontium, than MTA, and 
may induce rejection, inflammation, or allergic 
reactions5,18. Another study19 showed that variable 
amounts of chromium, nickel, and cobalt were 
contained in some commercial Portland cements4.
In clinical endodontic procedures, MTA is used 
in less than 1 g. Considering that the median lethal 
dose (LD50) for arsenic trioxide administered orally 
is 2 to 3 mg per kg of body weight, the toxic dose 
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for an individual weighing 70 kg would be 140 to 
210 mg, whereas this amount is considerably higher 
than the arsenic content present in the Portland 
cement used for a root end filling. Despite the fact 
that the cement with the lower amount of arsenic 
according to the ISO standard (WPC Irajazinho) has 
not produced lower values of inflammatory cells, 
cements with higher amounts of arsenic, as 18 
mg/kg, are able to produce a severe inflammatory 
reaction that showed a statistically lower amount 
of fibers and higher amount of inflammatory cells.
CONCLUSIONS
There was no direct relationship between 
the concentration of arsenic present in the 
composition of the materials and the intensity of the 
inflammatory reaction. Higher values as 18.46 mg/
kg of arsenic in the cement produce characteristics 
of severe inflammatory reaction at the 60-day 
period. The best results were found in MTA Angelus.
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